Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Snapshot
Insulin (from the Latin, insula meaning island) is a peptide hormone produced by beta cells of the pancreatic islets. It regulates the metabolism of carbohydrates, fats and protein by promoting the absorption of, especially, glucose from the blood into fat, liver and skeletal muscle cells.In these tissues the absorbed glucose is converted into either glycogen via glycogenesis or fats (triglycerides) via lipogenesis, or, in the case of the liver, into both.Glucose production (and excretion into the blood) by the liver is strongly inhibited by high concentrations of insulin in the blood.Circulating insulin also affects the synthesis of proteins in a wide variety of tissues. It is therefore an anabolic hormone, promoting the conversion of small molecules in the blood into large molecules inside the cells. Low insulin levels in the blood have the opposite effect by promoting widespread catabolism.
The Asia-Pacific Insulin market will reach xxx Million USD in 2018 and CAGR xx% 2018-2023. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Insulin by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Ultra-short-acting insulin
Short-acting insulin
In effect insulin
Long-acting insulin
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Novartis
Novo Nordisk
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly
MannKind
Sanofi
Merck
Bioton
GEA
Emisphere
Salix Pharmaceuticals
Gan & Lee
Dongbao
United Laboratories (TUL)
Takeda Pharmaceutical Company
Shihuida PHARMA Group
Henan Tian Fang Pharmaceutical
Disha Pharmaceutical Group
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Type 1 diabetes
Type 2 diabetes
Others diabetes
Region Coverage (Regional Production, Demand & Forecast by Regions etc.):
China
Japan & Korea
India
Southeast Asia
Oceania
Insulin (from the Latin, insula meaning island) is a peptide hormone produced by beta cells of the pancreatic islets. It regulates the metabolism of carbohydrates, fats and protein by promoting the absorption of, especially, glucose from the blood into fat, liver and skeletal muscle cells.In these tissues the absorbed glucose is converted into either glycogen via glycogenesis or fats (triglycerides) via lipogenesis, or, in the case of the liver, into both.Glucose production (and excretion into the blood) by the liver is strongly inhibited by high concentrations of insulin in the blood.Circulating insulin also affects the synthesis of proteins in a wide variety of tissues. It is therefore an anabolic hormone, promoting the conversion of small molecules in the blood into large molecules inside the cells. Low insulin levels in the blood have the opposite effect by promoting widespread catabolism.
The Asia-Pacific Insulin market will reach xxx Million USD in 2018 and CAGR xx% 2018-2023. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Insulin by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Ultra-short-acting insulin
Short-acting insulin
In effect insulin
Long-acting insulin
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Novartis
Novo Nordisk
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly
MannKind
Sanofi
Merck
Bioton
GEA
Emisphere
Salix Pharmaceuticals
Gan & Lee
Dongbao
United Laboratories (TUL)
Takeda Pharmaceutical Company
Shihuida PHARMA Group
Henan Tian Fang Pharmaceutical
Disha Pharmaceutical Group
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Type 1 diabetes
Type 2 diabetes
Others diabetes
Region Coverage (Regional Production, Demand & Forecast by Regions etc.):
China
Japan & Korea
India
Southeast Asia
Oceania
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
